Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 2, 2005, Pages 571-577

  Maus, Courtney E ^a,b   Plikaytis, Bonnie B ^b   Shinnick, Thomas M ^b,c  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; CIPROFLOXACIN; ETHAMBUTOL; ETHIONAMIDE; GENOMIC DNA; ISONIAZID; KANAMYCIN; PRIMER DNA; RIFAMPICIN; STREPTOMYCIN; VIOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM COLONY; BACTERIUM MUTANT; CONTROLLED STUDY; DRUG MECHANISM; GENE MUTATION; GENETIC COMPLEMENTATION; GENETIC TRANSCRIPTION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIBOSOME; RNA TRANSLATION; TRANSPOSON; WILD TYPE;

ANTIBIOTICS, ANTITUBERCULAR; BACTERIAL PROTEINS; BLOTTING, SOUTHERN; CAPREOMYCIN SULFATE; CLONING, MOLECULAR; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENE LIBRARY; HEMOLYSIN PROTEINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS; MUTATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PLASMIDS; PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; TRANSCRIPTION, GENETIC; TUBERCULOSIS; VIOMYCIN;

EID: 12944255782     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.2.571-577.2005     Document Type: Article

References (45)

1. Alangaden, G. J., B. N. Kreiswirth, A. Aouad, M. Khetarpal, F. R. Igno, S. L. Moghazeh, E. K. Manavathu, and S. A. Lerner. 1998. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42:1295-1297.
2. Algeorge, G., and A. Petre. 1970. Some experimental aspects of cross-resistance between capreomycin and viomycin. Antibiot. Chemother. 16:32-35.
3. Aravind, L., and E. V. Koonin. 1999. Novel predicted RNA-binding domains associated with the translation machinery. J. Mol. Evol. 48:291-302.
4. Blumberg, H. M., W. J. Burman, R. E. Chaisson, C. L. Daley, S. C. Etkind, L. N. Friedman, P. Fujiwara, M. Grzemska, P. C. Hopewell, M. D. Iseman, R. M. Jasmer, V. Koppaka, R. I. Menzies, R. J. O'Brien, R. R. Reves, L. B. Reichman, P. M. Simone, J. R. Starke, and A. A. Vernon. 2003. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am. J. Respir. Crit. Care Med. 167:603-662.
5. Bugl, H., E. B. Fauman, B. L. Staker, F. Zheng, S. R. Kushner, M. A. Saper, J. C. Bardwell, and U. Jakob. 2000. RNA methylation under heat shock control. Mol. Cell 6:349-360.
6. Caldas, T., E. Binet, P. Bouloc, A. Costa, J. Desgres, and G. Richarme. 2000. The FtsJ/RrmJ heat shock protein of Escherichia coli is a 23 S ribosomal RNA methyltransferase. J. Biol. Chem. 275:16414-16419.
7. Camus, J. C., M. J. Pryor, C. Medigue, and S. T. Cole. 2002. Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 148:2967-2973.
8. Choi, E. C., M. Misumi, T. Nishimura, N. Tanaka, S. Nomoto, T. Teshima, and T. Shiba. 1979. Viomycin resistance: alterations of either ribosomal subunit affect the binding of the antibiotic to the pair subunit and the entire ribosome becomes resistant to the drug. Biochem. Biophys. Res. Commun. 87:904-910.
9. Cirillo, J. D., R. G. Barletta, B. R. Bloom, and W. R. Jacobs, Jr. 1991. A novel transposon trap for mycobacteria: isolation and characterization of 1S1096. J. Bacteriol. 173:7772-7780.
10. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, B. G. Barrell, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
11. De Stasio, E. A., D. Moazed, H. F. Noller, and A. E. Dahlberg. 1989. Mutations in 16S ribosomal RNA disrupt antibiotic-RNA interactions. EMBO J. 8:1213-1216.
12. Dye, C., M. A. Espinal, C. J. Watt, C. Mbiaga, and B. G. Williams. 2002. Worldwide incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 185:1197-1202.
13. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677-686.
14. Farmer, P., and J. Y. Kim. 1998. Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus." BMJ 317:671-674.
15. Feder, M., J. Pas, L. S. Wyrwicz, and J. M. Bujnicki. 2003. Molecular phylogenetics of the RrmJ/fibrillarin superfamily of ribose 2′-O- methyltransferases. Gene 302:129-138.
16. Formenoy, L. J., P. R. Cunningham, K. Nurse, C. W. Pleij, and J. Ofengand. 1994. Methylation of the conserved A1518-A1519 in Escherichia coli 16S ribosomal RNA by the ksgA methyltransferase is influenced by methylations around the similarly conserved U1512. G1523 base pair in the 3′ terminal hairpin. Biochimie 76:1123-1128.
17. Guilhot, C., B. Gicquel, J. Davies, and C. Martin. 1992. Isolation and analysis of IS6120, a new insertion sequence from Mycobacterium smegmatis. Mol. Microbiol. 6:107-113.
18. Hager, J., B. L. Staker, H. Bugl, and U. Jakob. 2002. Active site in RrmJ, a heat shock-induced methyltransferase. J. Biol. Chem. 277:41978-41986.
19. Kikuta-Oshima, L. C., F. D. Quinn, W. R. Butler, T. M. Shinnick, and C. H. King. 1995. Isolation of RNA from Mycobacterium tuberculosis using a nitrogen decompression chamber. BioTechniques 18:987-990.
20. Koseki, Y., and S. Okamoto. 1963. Studies on cross-resistance between capreomycin and certain other anti-mycobacterial agents. Jpn. J. Med. Sci. Biol. 16:31-38.
21. McClatchy, J. K., W. Kanes, P. T. Davidson, and T. S. Moulding. 1977. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin. Tubercle 58:29-34.
22. Mizuguchi, Y., K. Suga, and T. Yamada. 1979. Interaction between 30 S ribosomal components in a viomycin-resistant mutant of Mycobacterium smegmatis. Microbiol. Immunol. 23:595-604.
23. Modolell, J., and D. Vazquez. 1977. The inhibition of ribosomal translocation by viomycin. Eur. J. Biochem. 81:491-497.
24. National Committee for Clinical laboratory Standards. 2003. Susceptibility testing of Mycobacteria, Norcardiae, and other aerobic actinomycetes. Approved standard M24-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
25. Parish, T., E. Mahenthiralingam, P. Draper, E. O. Davis, and M. J. Colston. 1997. Regulation of the inducible acetamidase gene of Mycobacterium smegmatis. Microbiology 143:2267-2276.
26. Paunescu, E., M. Stoinescu, C. Zaharescu, and E. Dragusanu. 1970. Some correlations between chemical structure and mode of action of tuberculostatica. Researches on capreomycin and isoxyl. Antibiot. Chemother. 16:10-16.
27. Plikajtis, B. B., J. T. Crawford, and T. M. Shinnick. 1998. IS1549 from Mycobacterium smegmatis forms long direct repeats upon insertion. J. Bacteriol. 180:1037-1043.
28. Ramaswamy, S., and J. M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29.
29. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
30. Sander, P., A. Meier, and E. C. Bottger. 1996. Ribosomal drug resistance in mycobacteria. Res. Microbiol. 147:59-67.
31. Sutton, W. B., R. S. Gordee, W. E. Wick, and L. Stanfield. 1966. In vitro and in vivo laboratory studies on the antituberculous activity of capreomycin. Ann. N. Y. Acad. Sci. 135:947-959.
32. Suzuki, Y., C. Katsukawa, A. Tamaru, C. Abe, M. Makino, Y. Mizuguchi, and H. Taniguchi. 1998. Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J. Clin. Microbiol. 36:1220-1225.
33. Taniguchi, H., B. Chang, C. Abe, Y. Nikaido, Y. Mizuguchi, and S. I. Yoshida. 1997. Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system. J. Bacteriol. 179:4795-4801.
34. Trnka, L., and D. W. Smith. 1970. Proteosynthetic activity of isolated ribosomes of mycobacteria and its alteration by rifampicin and related tuberculostatic drugs. Antibiot. Chemother. 16:369-379.
35. Tsukamura, M. 1969. Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubercle bacilli from patients. Am. Rev. Respir. Dis. 99:780-782.
36. Tsukamura, M., and S. Mizuno. 1975. Cross-resistance relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis. J. Gen. Microbiol. 88:269-274.
37. Vila-Sanjurjo, A., and A. E. Dahlberg. 2001. Mutational analysis of the conserved bases C1402 and A1500 in the center of the decoding domain of Escherichia coli 16 S rRNA reveals an important tertiary interaction. J. Mol. Biol. 308:457-463.
38. Walsh, C. 2000. Molecular mechanisms that confer antibacterial drug resistance. Nature 406:775-781.
39. Wren, B. W., R. A. Stabler, S. S. Das, P. D. Butcher, J. A. Mangan, J. D. Clarke, N. Casali, T. Parish, and N. G. Stoker. 1998. Characterization of a haemolysin from Mycobacterium tuberculosis with homology to a virulence factor of Serpulina hyodysenteriae. Microbiology 144:1205-1211.
40. Yamada, T., K. Masuda, K. Shoji, and M. Hori. 1972. Analysis of ribosomes from viomycin-sensitive and -resistant strains of Mycobacterium smegmatis. J. Bacteriol. 112:1-6.
41. Yamada, T., Y. Mizugichi, K. H. Nierhaus, and H. G. Wittmann. 1978. Resistance to viomycin conferred by RNA of either ribosomal subunit. Nature 275:460-461.
42. Yamada, T., Y. Mizuguchi, and K. Suga. 1976. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis. J. Antibiot. (Tokyo) 29:1124-1126.
43. Yamada, T., A. Nagata, Y. Ono, Y. Suzuki, and T. Yamanouchi. 1985. Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 27:921-924.
44. Yamada, T., and K. H. Nierhaus. 1978. Viomycin favours the formation of 70S ribosome couples. Mol. Gen. Genet. 161:261-265.
45. Zierski, M. 1969. Capreomycin and other drugs in the treatment of pulmonary tuberculosis. Tubercle 50(Suppl.):37-39.